Australia Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook
Australia viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
Australia viral vector and plasmid dna manufacturing market highlights
- The Australia viral vector and plasmid dna manufacturing market generated a revenue of USD 53.9 million in 2023 and is expected to reach USD 207.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 21.3% from 2024 to 2030.
- In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
- Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
Viral vector and plasmid dna manufacturing market data book summary
| Market revenue in 2023 | USD 53.9 million |
| Market revenue in 2030 | USD 207.7 million |
| Growth rate | 21.3% (CAGR from 2023 to 2030) |
| Largest segment | Adeno-associated virus (aav) |
| Fastest growing segment | Adeno-associated virus (AAV) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
| Key market players worldwide | Merck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.0% of the global viral vector and plasmid dna manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China viral vector and plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,175.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vector And Plasmid DNA Manufacturing Market Scope
Viral Vector And Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia viral vector and plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 20.22% in 2023. Horizon Databook has segmented the Australia viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
Australia Excellent research facilities, world-class researchers, and a firm but flexible regulatory framework have made Australia a powerhouse of pharmaceutical and biotechnology innovation.
According to the data published by the Australian Trade and Investment Commission, Australia has become a hub for a thriving network of more than 470 biotechnology companies.
Significant presence of established pharmaceutical & biotechnology companies and extensive R&D initiatives being undertaken by them are expected to create high demand for viral vectors and plasmid DNA manufacturing solutions & systems in the country.
Reasons to subscribe to Australia viral vector and plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia viral vector and plasmid dna manufacturing market databook
-
Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Australia viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)
Australia Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
